Stockscreener 앱 받기
1.15
4.55%
0.05
시간 외 거래:
1.09
-0.06
-5.22%
전일 마감가:
$1.10
열려 있는:
$1.06
하루 거래량:
198.64K
Relative Volume:
1.05
시가총액:
$3.99M
수익:
$17.72M
순이익/손실:
$-3.37M
주가수익비율:
-0.5643
EPS:
-2.038
순현금흐름:
$-3.72M
1주 성능:
+5.50%
1개월 성능:
+5.50%
6개월 성능:
-67.61%
1년 성능:
-61.02%
1일 변동 폭
$1.03
$1.26
1주일 범위
$1.03
$1.26
52주 변동 폭
$0.8501
$6.9199
소노마 파머 Stock (SNOA) Company Profile
명칭
Sonoma Pharmaceuticals Inc
전화
800-759-9305
주소
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
1.15 | 3.86M | 17.72M | -3.37M | -3.72M | -2.038 |
TAK
Takeda Pharmaceutical Co Adr
|
15.42 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.87 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.56 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.26 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
551.47 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
소노마 파머 주식(SNOA)의 최신 뉴스
SNOA Q1 2026 Earnings: EPS Misses Estimates Amid Operational and Revenue Disclosures - newsline.com
SNOA Should I Buy - Intellectia AI
Sonoma Pharmaceuticals Q1 2026 Earnings: EPS Miss Triggers Sharp SelloffCFO Commentary Report - newsline.com
Sonoma Pharmaceuticals Inc. (SNOA) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock Unchanged - newsline.com
Sonoma Pharmaceuticals (SNOA) Edges Higher, Testing Resistance at $1.13Channel Breakout - The Legal Advocate
SNOA Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains UnreportedEnergy Earnings Report - newsline.com
Sonoma Pharmaceuticals Inc. (SNOA) Q1 2026 Earnings: EPS Slightly Misses Estimates Amid Thin Revenue DisclosuresOne-Time Gain Impact - newsline.com
Sonoma Pharmaceuticals (SNOA) Edges Higher, Testing Key Resistance at $1.13Volatility Smirk - Newser
SNOA SEC FilingsSonoma Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
Sonoma Pharmaceuticals (SNOA) Slips -3.56%, Testing $1.08 Support 2026-05-15Fast Rising Stocks - Newser
Sonoma Pharmaceuticals (SNOA) Q1 2026 Earnings Miss by Significant: Key TakeawaysRevenue Guidance Update - Newser
SNOA Director Jacoby Vanessa Stock Option Filing, May 14, 2026 - Meyka
Sonoma Pharmaceuticals (SNOA) outlines plan to reincorporate from Delaware to Nevada - Stock Titan
Sonoma Pharmaceuticals Completes Equity Offering to Raise Capital - The Globe and Mail
Sonoma Pharmaceuticals Prices $1.35 Unit Offering, Nets ~$3.5M Under Underwriting With Dawson James - TradingView
Sonoma Pharmaceuticals (NASDAQ: SNOA) closes $4M stock and warrant sale - Stock Titan
SNOA Sonoma Pharmaceuticals reports narrow Q1 2026 EPS miss as shares rise 1.92 percent on mild positive investor sentiment.Cost Advantage - Newser
SNOA Director Jacoby Vanessa Stock Option Filing, April 28, 2026 - Meyka
Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law - MSN
What's Going On With Sonoma Pharma Stock Monday? - Benzinga
2.96M-unit offering priced at $1.35 — Sonoma Pharmaceuticals (NASDAQ: SNOA) - Stock Titan
SNOA Drops As Sonoma Pharmaceuticals Launches Dilutive Offering - StocksToTrade
Sonoma Pharmaceuticals (SNOA) Secures $4M in Public Offering - GuruFocus
Sonoma Pharmaceuticals prices $4M stock offering at $1.35 per share - Investing.com
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering - ACCESS Newswire
[EFFECT] Sonoma Pharmaceuticals, Inc. SEC Filing - Stock Titan
Sonoma Pharmaceuticals (NASDAQ: SNOA) files S-1 for $5M unit and warrant sale - Stock Titan
SNOA (Sonoma Pharmaceuticals Inc.) Q1 2026 revenue growth drives 2.75 percent share gain despite narrow EPS miss.ROE - UBND thành phố Hải Phòng
SNOA Sonoma Pharmaceuticals shares jump 15 percent on 12 percent Q1 2026 revenue growth despite minor EPS miss.Crowd Entry Points - newser.com
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), Sonoma Pharmaceuticals, Inc. announced the launch of a public offering, aiming to raise a total of $5 million through the issuance of units. - Exchange Bitget
Sonoma Pharmaceuticals IncOffers Units In Public Offering For Gross Proceeds Of $5 MillionSEC Filing - TradingView
Sonoma Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933 - Moomoo
Sonoma Pharmaceuticals (NASDAQ: SNOA) plans $5M stock and warrant sale - Stock Titan
Will Sonoma Pharmaceuticals Inc stock go up in YEARQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
US Stocks Recap: Can Sonoma Pharmaceuticals Inc expand into new marketsWeekly Trade Report & Safe Capital Growth Tips - baoquankhu1.vn
3 Biotech Stocks Surge with Momentum - National Today
Sonoma Pharmaceuticals and Kenvue Brands Sign Manufacturing and Supply Agreement for Microcyn® Technology Products Through 2027 - Minichart
Sonoma Pharmaceuticals enters manufacturing agreement with Kenvue Brands - Investing.com
Sonoma Pharmaceuticals Enters U.S. Manufacturing and Supply Pact With Kenvue for Microcyn Line - TradingView — Track All Markets
Sonoma Pharmaceuticals (SNOA) signs Kenvue U.S. Microcyn manufacturing and supply deal - Stock Titan
Sonoma Pharmaceuticals, Inc. Enters Manufacturing And Supply Agreement With Kenvue Brands LLC - marketscreener.com
Breakout Move: Is Sonoma Pharmaceuticals Inc currently under institutional pressure2026 Intraday Action & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Is Sonoma Pharmaceuticals (SNOA) Stock Worth Holding | Price at $2.33, Down 1.90%Trend Following Picks - newsline.com
Aug Opening: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin - The Patriot Ledger
Sonoma Pharmaceuticals (SNOA) jumps 16% after hours on burn relief hydrogel launch in Walmart, CVS - msn.com
Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS - Benzinga
Market Wrap: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Published on: 2026-03-26 16:02:54 - baoquankhu1.vn
소노마 파머 (SNOA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.95%
1.13%
자본화:
|
볼륨(24시간):